Defining distinct features of anti-MOG antibody associated central nervous system demyelination
Extensive research over the last decades basically failed to identify a common cause of noninfectious inflammatory central nervous system (CNS) demyelinating disease. To a great extent, this may reflect that the group of inflammatory CNS demyelinating disorders likely contains multiple pathogenetica...
Main Authors: | Martin S. Weber, Tobias Derfuss, Imke Metz, Wolfgang Brück |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2018-03-01
|
Series: | Therapeutic Advances in Neurological Disorders |
Online Access: | https://doi.org/10.1177/1756286418762083 |
Similar Items
-
Influence of type I IFN signaling on anti-MOG antibody-mediated demyelination
by: Carsten Tue Berg, et al.
Published: (2017-06-01) -
A Fulminant Case of Demyelinating Encephalitis With Extensive Cortical Involvement Associated With Anti-MOG Antibodies
by: Sonja Hochmeister, et al.
Published: (2020-02-01) -
Anti-MOG autoantibodies pathogenicity in children and macaques demyelinating diseases
by: Che Serguera, et al.
Published: (2019-11-01) -
Case Report: Anti-NMDAR Encephalitis With Anti-MOG CNS Demyelination After Recurrent CNS Demyelination
by: Bing-Yan Ren, et al.
Published: (2021-02-01) -
Myelin Oligodendrocyte Glycoprotein (MOG)-IgG associated demyelinating disease: Our experience with this distinct syndrome
by: Shripad S Pujari, et al.
Published: (2021-01-01)